Low level laser therapy partially restores trachea muscle relaxation response in rats with tumor necrosis factor alpha-mediated smooth airway muscle dysfunction
- PMID: 16868933
- DOI: 10.1002/lsm.20357
Low level laser therapy partially restores trachea muscle relaxation response in rats with tumor necrosis factor alpha-mediated smooth airway muscle dysfunction
Abstract
Background and objective: It is unknown if the decreased ability to relax airway smooth muscles in asthma and other inflammatory airways disorders can be influenced by low level laser therapy (LLLT) irradiation. To investigate if LLLT could reduce impairment in inflamed trachea smooth muscles (TSM) in rats.
Study design/materials and methods: Controlled rat study where trachea was dissected and mounted in an organ bath apparatus with or without a TNF-alpha solution.
Results: Low level laser therapy administered perpendicularly to a point in the middle of the dissected trachea with a wavelength of 655 nm and a dose of 2.6 J/cm(2), partially restored TSM relaxation response to isoproterenol. Tension reduction was 47.0 % (+/-2.85) in the laser-irradiated group compared to 22.0% (+/-2.21) in the control group (P < 0.01). Accumulation of cAMP was almost normalized after LLLT at 22.3 pmol/mg (+/-2.1) compared to 17.6 pmol/mg (+/-2.1) in the non-irradiated control group (P < 0.01).
Conclusion: Low level laser therapy partially restores the normal relaxation response in inflamed TSM and normalizes accumulation of cAMP in the presence of isoproterenol.
(c) 2006 Wiley-Liss, Inc.
Similar articles
-
Low level laser therapy (LLLT): attenuation of cholinergic hyperreactivity, beta(2)-adrenergic hyporesponsiveness and TNF-alpha mRNA expression in rat bronchi segments in E. coli lipopolysaccharide-induced airway inflammation by a NF-kappaB dependent mechanism.Lasers Surg Med. 2009 Jan;41(1):68-74. doi: 10.1002/lsm.20735. Lasers Surg Med. 2009. PMID: 19143014
-
Cytokine mRNA expression is decreased in the subplantar muscle of rat paw subjected to carrageenan-induced inflammation after low-level laser therapy.Photomed Laser Surg. 2008 Feb;26(1):19-24. doi: 10.1089/pho.2007.2119. Photomed Laser Surg. 2008. PMID: 18248157
-
Anti-Inflammatory effects of low-level laser therapy (660 nm) in the early phase in carrageenan-induced pleurisy in rat.Lasers Surg Med. 2008 Sep;40(7):500-8. doi: 10.1002/lsm.20658. Lasers Surg Med. 2008. PMID: 18727002
-
The ability of low level laser therapy to prevent muscle tissue damage induced by snake venom.Photochem Photobiol. 2009 Jan-Feb;85(1):63-9. doi: 10.1111/j.1751-1097.2008.00397.x. Epub 2008 Jul 17. Photochem Photobiol. 2009. PMID: 18643907
-
Low-level laser therapy (LLLT) prevents oxidative stress and reduces fibrosis in rat traumatized Achilles tendon.Lasers Surg Med. 2005 Oct;37(4):293-300. doi: 10.1002/lsm.20225. Lasers Surg Med. 2005. PMID: 16196040
Cited by
-
The Effect of Low-Level Laser Therapy on the Acceleration of Orthodontic Tooth Movement.J Lasers Med Sci. 2020 Spring;11(2):204-211. doi: 10.34172/jlms.2020.34. Epub 2020 Mar 15. J Lasers Med Sci. 2020. PMID: 32273964 Free PMC article. Review.
-
Low-level laser therapy (LLLT) acts as cAMP-elevating agent in acute respiratory distress syndrome.Lasers Med Sci. 2011 May;26(3):389-400. doi: 10.1007/s10103-010-0874-x. Epub 2010 Dec 24. Lasers Med Sci. 2011. PMID: 21184127
-
Low level laser therapy (LLLT) decreases pulmonary microvascular leakage, neutrophil influx and IL-1beta levels in airway and lung from rat subjected to LPS-induced inflammation.Inflammation. 2008 Jun;31(3):189-97. doi: 10.1007/s10753-008-9064-4. Epub 2008 Apr 18. Inflammation. 2008. PMID: 18421573
-
Comparative evaluation of low-level light therapy and ethinyl estradiol and desogestrel combined oral contraceptive for clinical efficacy and regulation of serum biochemical parameters in primary dysmenorrhoea: a prospective randomised multicentre trial.Lasers Med Sci. 2022 Jun;37(4):2239-2248. doi: 10.1007/s10103-021-03490-z. Epub 2022 Jan 14. Lasers Med Sci. 2022. PMID: 35028764 Free PMC article. Clinical Trial.
-
The Cholinergic Drug Pyridostigmine Alleviates Inflammation During LPS-Induced Acute Respiratory Distress Syndrome.Front Pharmacol. 2021 May 4;12:624895. doi: 10.3389/fphar.2021.624895. eCollection 2021. Front Pharmacol. 2021. PMID: 34017249 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources